In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

XBP1-US/XBP1-SP/CD138/CS1 multipeptide vaccine PVX-410 
A cancer vaccine containing immunogenic, HLA-A2-specific epitopes derived from X-box–binding protein 1-unspliced (XBP1-US), XBP1-spliced (SP), syndecan-1 (CD138), and CS1 (CD2 subset 1, CRACC, SLAMF7, CD319) with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration, XBP1-US/XBP1-SP/CD138/CS1 multipeptide vaccine PVX-410 may stimulate the immune system to induce a cytotoxic T-lymphocyte response against the four myeloma-specific antigens. The tumor associated antigens (TAAs) XBP1-US, XBP1-SP, CD138 and CS1, are overexpressed on the surface of multiple myeloma (MM) cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name:PVX-410